Back to search results
NCT07632820

Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain

Recruiting
PHASE4Ages 18–80InterventionalTreatment
Mayo Clinic
~76 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Erector Spinae Plane (ESP) Block with 0.5% Plain BupivacaineTrigger Point Injection (TPI) with 0.5% Plain Bupivacaine

At a glance

Recruiting sites
1 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Numeric Rating Scale (NRS) Pain Score
Measured over baseline, 6 weeks

Conditions

Back Pain

Explore related trials

Thoracic Myofascial Pain

Where it's being run

5 sites across 5 states
Florida1
Maryland1
Minnesota1
Ohio1
Texas1

Study leadership

  • Ryan D'Souza, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Ryan D'Souza, MD
[email protected]
507-284-9696
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults aged 18-80 years
Chronic thoracic myofascial pain lasting at least three months
Pain intensity of ≥4 on 11-point NRS
At least two of three following conditions: Focal thoracic paraspinal pain, palpable taut band, referred pain pattern with palpation

Exclusion

Thoracic radiculopathy
Cervical myelopathy with neurological deficit
Prior cervicothoracic spine surgery
Pregnancy or lactation
Contraindication to local anesthetic
Active malignancy
Fibromyalgia
BMI \>40 kg/m2
Workers' compensation or active litigation related to thoracic pain
Acute herpes zoster or history of postherpetic neuralgia involving thoracic dermatomes
Current opioid use \>50 morphine milligram equivalents daily
Severe psychiatric or cognitive disorders, specifically history of schizophrenia, chronic psychotic disorders, dementia
History of substance use disorder
Inability to provide informed consent

What this trial measures

  • Numeric Rating Scale (NRS) Pain Scorebaseline, 6 weeks

    A Numeric Rating Scale (NRS) for pain is a patient-reported item regarding the level of pain experienced and is measured on a Likert scale from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable".